Status:

COMPLETED

Long Term Outcomes of Coronavirus Disease-19 (COVID-19)

Lead Sponsor:

Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital

Collaborating Sponsors:

Turkish Respiratory Society

Conditions:

Covid19

Eligibility:

All Genders

18-90 years

Brief Summary

The investigators hypothese that lung involvement due to COVID-19 may cause structural changes in the lung in the long term. In this study the effects of structural changes in the lung on pulmonary fu...

Detailed Description

Coronavirus disease-19 (COVID-19) has a clinical spectrum ranging from asymptomatic cases to severe cases requiring intensive care hospitalization due to respiratory failure. The disease mostly infect...

Eligibility Criteria

Inclusion

  • Patients who were ≥18 years
  • COVID-19 confirmed by Real-Time PCR
  • At least 6 months after discharge

Exclusion

  • Patients who were \< 18 years
  • Pregnancy
  • Become bedridden after discharge

Key Trial Info

Start Date :

January 15 2021

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

June 1 2021

Estimated Enrollment :

70 Patients enrolled

Trial Details

Trial ID

NCT04715919

Start Date

January 15 2021

End Date

June 1 2021

Last Update

September 14 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

1University of Health Sciences Turkey, Dr Suat Seren Chest Diseases and Chest Surgery Training and Research Hospital, Intensive Care Unit

Izmir, Turkey (Türkiye), 35110